| HBAN |
Report |
Net Interest Income (Q2 2026) |
MISS |
pred ~$2,060M vs. cons $2,093M |
MEDIUM |
| HBAN |
Report |
Fee Income / Noninterest Income (Q2 2026) |
BEAT |
pred ~$760M vs. cons $734M |
MEDIUM |
| HBAN |
Report |
NCO Ratio (Q2 2026) |
BEAT |
pred ~24bp vs. cons 26.4bp |
HIGH |
| HBAN |
Guide |
FY2026 NII (full year) |
UNCHANGED |
guide maintained vs. cons $8,330M |
MEDIUM |
| HBAN |
Guide |
FY2026 Fee Income (full year) |
BETTER |
guide raised to 33-35% growth vs. cons $2,947M |
MEDIUM |
| HBAN |
Guide |
NIM Exit Rate (qualitative, FY2026) |
BETTER |
upgraded to low 3.30s vs. current high 3.20s |
MEDIUM |
| HBAN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.0% |
— |
MEDIUM |
| HBAN |
Return |
5-day cumulative residual |
-2.0% (FADE) |
FADE — sell-side cuts Q3 NII on the miss; fee/NIM upgrade partially offsets but does not prevent estimate drift lower |
MEDIUM |